|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Cyteir Therapeutics, Inc. (CYT) |
|
|
$3.02 0.00 (0.00%) as of 4:30 Fri 3/15
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
35,370,000 |
Market
Cap: |
106.82(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.74 - $3.15 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Cyteir Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing the oncology medicines that inhibit deoxyribonucleic acid damage repair and cause cancer cell death in specific subsets of cancer patients through a therapeutic strategy known as synthetic lethality. Co.'s primary program, CYT-0851, was identified through a phenotypic screening strategy that exploited a synthetic lethality between cytidine deaminases (CD) overexpression and homologous recombination inhibition. The screen was designed to select for compounds that induced synthetic lethality in CD-overexpressing cancer cells while sparing normal cells.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
284,366 |
284,366 |
284,366 |
366,717 |
Total Buy Value |
$845,707 |
$845,707 |
$845,707 |
$989,543 |
Total People Bought |
1 |
1 |
1 |
3 |
Total Buy Transactions |
2 |
2 |
2 |
7 |
Total Shares Sold |
0 |
0 |
401,548 |
1,301,548 |
Total Sell Value |
$0 |
$0 |
$1,026,787 |
$3,726,787 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
14 |
15 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Novo A/s |
10% Owner |
|
2023-06-22 |
4 |
S |
$1.94 |
$9,783 |
D/D |
(5,041) |
3,907,411 |
|
-53% |
|
Novo A/s |
10% Owner |
|
2023-06-21 |
4 |
S |
$1.99 |
$9,641 |
D/D |
(4,834) |
3,912,452 |
|
-52% |
|
Novo A/s |
10% Owner |
|
2023-06-14 |
4 |
S |
$2.11 |
$6,050 |
D/D |
(2,872) |
3,934,015 |
|
-42% |
|
Novo A/s |
10% Owner |
|
2023-06-13 |
4 |
S |
$2.10 |
$5,515 |
D/D |
(2,626) |
3,936,887 |
|
-43% |
|
Novo A/s |
10% Owner |
|
2023-06-12 |
4 |
S |
$2.06 |
$1,858 |
D/D |
(900) |
3,939,513 |
|
-42% |
|
Renschler Markus Md |
President and CEO |
|
2023-01-13 |
4 |
A |
$1.49 |
$7,450 |
D/D |
5,000 |
983,736 |
|
- |
|
Gaiero David G |
Chief Financial Officer |
|
2023-01-13 |
4 |
A |
$1.49 |
$7,450 |
D/D |
5,000 |
9,100 |
|
- |
|
Zakrzewski Joseph S |
Director |
|
2022-12-07 |
4 |
B |
$1.30 |
$27,563 |
D/D |
21,202 |
154,618 |
2.39 |
54% |
|
Novo A/s |
10% Owner |
|
2022-07-20 |
4 |
S |
$3.00 |
$2,700,000 |
D/D |
(900,000) |
3,940,413 |
|
64% |
|
Zakrzewski Joseph S |
Director |
|
2022-05-12 |
4 |
B |
$1.61 |
$1,196 |
D/D |
743 |
133,416 |
2.31 |
19% |
|
Zakrzewski Joseph S |
Director |
|
2022-05-11 |
4 |
B |
$1.70 |
$1,700 |
D/D |
1,000 |
132,673 |
2.31 |
21% |
|
Thero John F |
Director |
|
2022-05-10 |
4 |
B |
$2.00 |
$20,000 |
D/D |
10,000 |
10,000 |
2.39 |
6% |
|
Zakrzewski Joseph S |
Director |
|
2022-05-10 |
4 |
B |
$1.89 |
$93,377 |
D/D |
49,406 |
131,673 |
2.39 |
6% |
|
Zakrzewski Joseph S |
Director |
|
2021-12-28 |
4 |
B |
$9.85 |
$5,920 |
D/D |
601 |
82,267 |
2.39 |
-81% |
|
Zakrzewski Joseph S |
Director |
|
2021-12-27 |
4 |
B |
$9.97 |
$3,002 |
D/D |
299 |
81,666 |
2.31 |
-80% |
|
Zakrzewski Joseph S |
Director |
|
2021-12-23 |
4 |
B |
$9.87 |
$1,974 |
D/D |
200 |
81,367 |
2.31 |
-77% |
|
Gaiero David G |
Chief Financial Officer |
|
2021-12-20 |
4 |
OE |
$1.68 |
$6,888 |
D/D |
4,100 |
4,100 |
|
- |
|
Zakrzewski Joseph S |
Director |
|
2021-12-17 |
4 |
B |
$9.88 |
$1,976 |
D/D |
200 |
81,167 |
2.31 |
-77% |
|
Zakrzewski Joseph S |
Director |
|
2021-12-15 |
4 |
B |
$10.47 |
$39,844 |
D/D |
3,700 |
80,967 |
2.39 |
-76% |
|
Naesens Janwillem |
Director |
|
2021-06-22 |
4 |
B |
$18.00 |
$4,999,986 |
I/I |
277,777 |
3,536,803 |
2.1 |
-2% |
|
Naesens Janwillem |
Director |
|
2021-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
3,259,026 |
3,259,026 |
|
- |
|
George Jean |
Director |
|
2021-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
2,444,268 |
2,444,268 |
|
- |
|
Zakrzewski Joseph S |
Director |
|
2021-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
58,671 |
58,671 |
|
- |
|
Naesens Janwillem |
10% Owner |
|
2021-06-22 |
4 |
B |
$18.00 |
$4,999,986 |
D/D |
277,777 |
3,536,803 |
2.45 |
-2% |
|
Naesens Janwillem |
10% Owner |
|
2021-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,259,026 |
3,259,026 |
|
- |
|
59 Records found
|
|
Page 2 of 3 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|